Literature DB >> 32388425

New lupane bidesmosides exhibiting strong cytotoxic activities in vitro.

Anna Korda1, Lucie Rárová2, Zbigniew Pakulski3, Miroslav Strnad4, Jana Oklešťková2, Kinga Kuczynska1, Piotr Cmoch1, Katarzyna Gwardiak1, Romuald Karczewski1.   

Abstract

Triterpene bidesmosides are considered as highly cytotoxic saponins, usually less toxic against normal cells than monodesmosides, and less haemolytic. Biological activity of the betulin-type bidesmosides, rarely found in Nature, and seldom prepared due to serious synthetic problems, is poorly recognized. We report herein a protocol for the preparation of disubstituted lupane saponins (betulin bidesmosides) by treatment of their benzoates with potassium carbonate in dichloromethane / methanol solution. Cytotoxicity of all compounds was tested in vitro for a series of cancer cell lines, as well as normal human skin BJ fibroblasts. Presence of l-rhamnose moiety is crucial for cytotoxicity of betulin bidesmosides. On the other hand, l-arabinose fragment connected to lupane C-3 carbon atom significantly decreases activity. Presented results clearly show that betulin bidesmosides have significant clinical potential as anticancer agents.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Betulin bidesmosides; Birch bark; Cytotoxic activity; Structure–activity relationship; Synthesis

Mesh:

Substances:

Year:  2020        PMID: 32388425     DOI: 10.1016/j.bioorg.2020.103868

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  1 in total

Review 1.  Semisynthetic Derivatives of Pentacyclic Triterpenes Bearing Heterocyclic Moieties with Therapeutic Potential.

Authors:  Gabriela Nistor; Cristina Trandafirescu; Alexandra Prodea; Andreea Milan; Andreea Cristea; Roxana Ghiulai; Roxana Racoviceanu; Alexandra Mioc; Marius Mioc; Viviana Ivan; Codruța Șoica
Journal:  Molecules       Date:  2022-10-03       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.